Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) Short Interest Down 79.7% in May

Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) was the recipient of a large decline in short interest in the month of May. As of May 28th, there was short interest totalling 1,500 shares, a decline of 79.7% from the May 13th total of 7,400 shares. Based on an average trading volume of 288,200 shares, the short-interest ratio is currently 0.0 days.

ENDV stock remained flat at $$0.03 during midday trading on Friday. 4,220 shares of the company’s stock traded hands, compared to its average volume of 590,237. Endonovo Therapeutics has a 12-month low of $0.01 and a 12-month high of $0.16. The stock’s 50-day moving average is $0.03.

Endonovo Therapeutics Company Profile

Endonovo Therapeutics, Inc, a biotechnology company, develops, manufactures, and distributes non-invasive electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.

See Also: What causes a recession?

Receive News & Ratings for Endonovo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endonovo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.